BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16552047)

  • 1. Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans.
    Ganley-Leal LM; Mwinzi PN; Cetre-Sossah CB; Andove J; Hightower AW; Karanja DM; Colley DG; Secor WE
    Infect Immun; 2006 Apr; 74(4):2169-76. PubMed ID: 16552047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study.
    Karanja DM; Hightower AW; Colley DG; Mwinzi PN; Galil K; Andove J; Secor WE
    Lancet; 2002 Aug; 360(9333):592-6. PubMed ID: 12241930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher percentages of circulating mast cell precursors correlate with susceptibility to reinfection with Schistosoma mansoni.
    Ganley-Leal LM; Mwinzi PN; Cetre-Sossah CB; Andove J; Hightower AW; Karanja DM; Colley DG; Secor WE
    Am J Trop Med Hyg; 2006 Dec; 75(6):1053-7. PubMed ID: 17172364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.
    Black CL; Mwinzi PN; Muok EM; Abudho B; Fitzsimmons CM; Dunne DW; Karanja DM; Secor WE; Colley DG
    PLoS Negl Trop Dis; 2010 Mar; 4(3):e637. PubMed ID: 20351784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control.
    Butterworth AE; Dunne DW; Fulford AJ; Thorne KJ; Gachuhi K; Ouma JH; Sturrock RF
    Immunol Invest; 1992 Aug; 21(5):391-407. PubMed ID: 1428017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies on mice vaccinated with irradiated cercaria and IL-12 against Schistosoma mansoni infection.
    el-Gawish MA; Moawad MA
    Egypt J Immunol; 2003; 10(2):39-48. PubMed ID: 15719610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
    Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.
    Wilson MS; Cheever AW; White SD; Thompson RW; Wynn TA
    PLoS Pathog; 2011 Aug; 7(8):e1002171. PubMed ID: 21829367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection.
    Mwinzi PN; Karanja DM; Colley DG; Orago AS; Secor WE
    J Infect Dis; 2001 Aug; 184(4):488-96. PubMed ID: 11471107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of co-stimulatory and adhesion molecules are observed on eosinophils during human Schistosoma mansoni infection.
    Silveira-Lemos D; Teixeira-Carvalho A; Martins-Filho OA; Oliveira LF; CorrĂȘa-Oliveira R
    Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():345-51. PubMed ID: 17308795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.
    Black CL; Muok EM; Mwinzi PN; Carter JM; Karanja DM; Secor WE; Colley DG
    J Infect Dis; 2010 Aug; 202(3):399-405. PubMed ID: 20560767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity in human schistosomiasis mansoni: prevention by blocking antibodies of the expression of immunity in young children.
    Butterworth AE; Bensted-Smith R; Capron A; Capron M; Dalton PR; Dunne DW; Grzych JM; Kariuki HC; Khalife J; Koech D
    Parasitology; 1987 Apr; 94 ( Pt 2)():281-300. PubMed ID: 2438629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections.
    Karanja DM; Colley DG; Nahlen BL; Ouma JH; Secor WE
    Am J Trop Med Hyg; 1997 May; 56(5):515-21. PubMed ID: 9180601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-infection with Schistosoma mansoni and Human Immunodeficiency Virus-1 (HIV-1) among residents of fishing villages of north-western Tanzania.
    Mazigo HD; Dunne DW; Wilson S; Kinung'hi SM; Pinot de Moira A; Jones FM; Morona D; Nuwaha F
    Parasit Vectors; 2014 Dec; 7():587. PubMed ID: 25511298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection.
    Joseph S; Jones FM; Laidlaw ME; Mohamed G; Mawa PA; Namujju PB; Kizza M; Watera C; Whitworth JA; Dunne DW; Elliott AM
    J Infect Dis; 2004 Aug; 190(3):613-8. PubMed ID: 15243939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation.
    Kayaba H; Dombrowicz D; Woerly G; Papin JP; Loiseau S; Capron M
    J Immunol; 2001 Jul; 167(2):995-1003. PubMed ID: 11441108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults.
    Brown M; Mawa PA; Joseph S; Bukusuba J; Watera C; Whitworth JA; Dunne DW; Elliott AM
    J Infect Dis; 2005 May; 191(10):1648-57. PubMed ID: 15838791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosoma mansoni infection and socio-behavioural predictors of HIV risk: a cross-sectional study in women from Uganda.
    Yegorov S; Galiwango RM; Good SV; Mpendo J; Tannich E; Boggild AK; Kiwanuka N; Bagaya BS; Kaul R
    BMC Infect Dis; 2018 Nov; 18(1):586. PubMed ID: 30453907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments.
    Mwinzi PN; Ganley-Leal L; Black CL; Secor WE; Karanja DM; Colley DG
    J Infect Dis; 2009 Jan; 199(2):272-9. PubMed ID: 19072134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.
    Dunne DW; Butterworth AE; Fulford AJ; Kariuki HC; Langley JG; Ouma JH; Capron A; Pierce RJ; Sturrock RF
    Eur J Immunol; 1992 Jun; 22(6):1483-94. PubMed ID: 1601036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.